Our website uses cookies to improve your on-site experience. By using the website, cookies are being used as described in our Policy Document
Warning: To log in you will need to enable cookies and reload the page (Policy Document)
My ePortfolio Register   
Clinical Study

Repurposing drugs in oncology (ReDO)—selective PDE5 inhibitors as anti-cancer agents

Cite this Article

To cite this article please use the text below.

Pantziarka Pan, Sukhatme Vidula, Crispino Sergio, Bouche Gauthier, Meheus Lydie and Sukhatme Vikas P (2018) Repurposing drugs in oncology (ReDO)—selective PDE5 inhibitors as anti-cancer agents ecancer 12 824



Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

ecancer Global Foundation